If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Bonus Share Issue and Total Voting Rights

15 Jul 2020 08:01

RNS Number : 0593T
Randall & Quilter Inv Hldgs Ltd
15 July 2020
 

 

Randall & Quilter Investment Holdings Ltd.

 

("R&Q", the "Group" or the "Company")

Bonus Share Issue and Total Voting Rights

15 July 2020

The Company is pleased to announce the admission of 9,676,676 new ordinary shares of 2p each to shareholders in accordance with a Bonus Share Issue approved at the Company's Annual General Meeting held on 9th July 2020.

Application was made to the London Stock Exchange for the admission of the 9,676,676 new ordinary shares of 2p each to trading on AIM and admission of the new shares took place on 15 July 2020.

As a result of the Bonus Share Issue the total issued share capital of the Company is 222,675,086. There are 111,525 held in Treasury and the total voting rights will therefore be 222,563,561. The figure of 222,563,561 ordinary shares of 2p each may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the DTRs.

 

-Ends-

 

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Stephane Auton

James Thomas

Tel: 020 7408 4090

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

 

 

Notes to Editors:

 

Notes to Editors:

 

About R&Q 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.

Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

For the financial year ended 31 December 2019 R&Q reported pre-tax profits of over £40 million.

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUVUNRRWUBARR
Date   Source Headline
29th Jul 20247:00 amRNSCancellation - R&Q INSURANCE HOLDINGS LTD
28th Jun 20246:07 pmRNSSale of Accredited to Onex Partners
27th Jun 20247:00 amRNSAppointment of Joint Provisional Liquidators
24th Jun 20247:00 amRNSUpdate
24th Jun 20247:00 amRNSR&Q agrees sale of Inceptum
20th Jun 20244:59 pmRNSTR-1: Notification of major holdings
20th Jun 20241:12 pmRNSTR-1: Notification of major holdings
19th Jun 20242:46 pmRNSTR-1: Notification of major holdings
19th Jun 20242:26 pmRNSTR-1: Notification of major holdings
19th Jun 20247:30 amRNSSuspension - R&Q Insurance Holdings Ltd
19th Jun 20247:00 amRNSUpdate
18th Jun 20242:19 pmRNSNotification of major holdings
17th Jun 20241:29 pmRNSTR-1: Notification of major holdings
14th Jun 20243:16 pmRNSTR-1: Notification of major holdings
13th Jun 20247:35 amRNSUpdate on proposed sale of Accredited
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.